Yvonne McGrath, VP, Research and Development at iTeos Therapeutics, Inc. (ITOS), sold 15,762 shares at $25.43 ($389K) on 2021-05-17, disclosed to the SEC on 2021-05-19.
Open-market sale of $389k ITOS by VP, Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.41 | 5,807 | $142K | 36.4% |
| 2 | $24.41 | 5,807 | $142K | 36.4% |
| 3 | $25.43 | 2,029 | $52K | 13.3% |
| 4 | $25.43 | 2,029 | $52K | 13.3% |
| 5 | $26.01 | 90 | $2K | 0.6% |
| Total | $24.68 avg | 15,762 |
| $389K |
| 100% |
| Filing → |
| ITOS | SELL | 2021-06-03 | $313K | — | Filing → |
| ITOS | SELL | 2021-06-03 | $348K | — | Filing → |